Literature DB >> 9264733

[Leishmania (Viannia) braziliensis Vianna, 1911 in French Guiana. Clinical, therapeutic and epidemiological considerations in the ninth human diagnosed case].

C P Raccurt1, R Pradinaud, P Couppie, B Moreau, F Pratlong, J P Dedet, P Cotellon, B Juminer, D Sainte-Marie.   

Abstract

The authors report the ninth case of cutaneous Leishmaniasis without mucosal involvement due to Leishmania (Viannia) braziliensis (isoenzymatic profile related to zymodeme MON-44) diagnosed in a legionnaire who recently arrived in French Guiana. The skin lesion as a single ulcerated nodule of the dorsum of the left ringfinger was cured after two courses of four intramuscular injections of pentamidine isothionate (total posology of pentamidine-base: 16.6 mg/kg). The transmission occurred during nocturnal trekking in forest and swamps just behind the coastal belt at Degrad Saramaka (7 km South of Kourou). In French Guiana, the good level of medical care and the early treatment of the majority of the cases of Leishmaniasis may explain the rarity of mucosal lesions. Since the clinical aspect of the lesion is not sufficient to prejudge the identity of the causative species, it is necessary to perform cultivation of Leishmania for iso-enzymatic identification. The adaptation of pentamidine doses and long term follow up of patients infected by L. (V.) braziliensis could be defined more precisely.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9264733

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  2 in total

1.  Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP.

Authors:  Stephane Simon; Mathieu Nacher; Bernard Carme; Celia Basurko; Amaury Roger; Antoine Adenis; Marine Ginouves; Magalie Demar; Pierre Couppie
Journal:  Trop Med Health       Date:  2017-02-28

2.  American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors.

Authors:  Rémi Loiseau; Cecile Nabet; Stephane Simon; Marine Ginouves; Paul Brousse; Denis Blanchet; Magalie Demar; Pierre Couppie; Romain Blaizot
Journal:  Int J Dermatol       Date:  2019-09-16       Impact factor: 2.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.